The impairment of HCCS leads to MLS syndrome by activating a non-canonical cell death pathway in the brain and eyes
Version of Record online: 22 JAN 2013
Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
EMBO Molecular Medicine
Volume 5, Issue 2, pages 280–293, February 2013
How to Cite
Indrieri, A., Conte, I., Chesi, G., Romano, A., Quartararo, J., Tatè, R., Ghezzi, D., Zeviani, M., Goffrini, P., Ferrero, I., Bovolenta, P. and Franco, B. (2013), The impairment of HCCS leads to MLS syndrome by activating a non-canonical cell death pathway in the brain and eyes. EMBO Mol Med, 5: 280–293. doi: 10.1002/emmm.201201739
- Issue online: 4 FEB 2013
- Version of Record online: 22 JAN 2013
- Accepted manuscript online: 13 DEC 2012 02:40AM EST
- Manuscript Accepted: 4 DEC 2012
- Manuscript Revised: 3 DEC 2012
- Manuscript Received: 13 JUL 2012
Total views by type:
Publication date: 22 Jan 2013. Cumulative views from 22 Jan 2013 - 1 Jun 2016.
- Total views: 1258
- Total PDF views: 486
- Total HTML views: 772
- * Although we update our data on a daily basis (not in real time), there may be a 48-hour delay before the most recent numbers are available.
About this data
Usage data should be viewed in relation to:
- the publication date (older articles will generally have higher usage).
- the relevance of the article to a broad community (some articles will be extremely important but to smaller sections of the research community), and
- the availability and usage of the article through other sources
Article usage data is not a precise measure of an individual article's importance and should only be considered alongside other measures of visibility/importance.